Synevo Clinical Trials Symposium 2016

Synevo Clinical Trials Symposium 2016

Dear colleagues and friends,

I am very pleased to announce you that we have reached this year at the 8th edition of our symposium organized in Bucharest, Romania.

We invite you all to join us for our event dedicated to professionals working in clinical research field, pharma sponsors, biotech companies and CRO’s representatives, investigators (clinicians and general practitioners, laboratory specialists (lab physicians, chemists, biologists, biochemists, etc.).

You will have the chance to listen presentations of very well known speakers, KOL in their field, into a relaxing environment where you can also build and cultivate relationships and do the networking with your peers.

The event is credited with CME credits.

Be the first to register on our website where you will find all necessary details of this professional meeting of Clinical Trials specialists. Please be aware that there is a limited number of participants.

Cristina Florescu Moraid, Md, Msc, EuSpLM
Regional Director Romania, Moldova, Bulgaria and Serbia Synevo Central Lab

4

Sections

15

Speakers

480

Participants

13

Countries

8

Years of tradition

AGENDA

  • 08:00-09:00Participants Registration and welcome coffee

    Ronda Hall, INTERCONTINENTAL Hotel Bucharest
  • 09:00-09:15Welcome and Opening Remarks

    Cristina Florescu Moraid, MD, MSc, EUSpLM - Synevo Central Lab Country Director Romania, Republic of Moldova, Bulgaria & Serbia
  • 09:15-11:55INVESTIGATOR SECTION

    Chairman for Investigator Section:
    Marius Geanta - MD, CEO Center for Innovation in Medicine, Romania

    9:15-9:45 AM
    Victoria Arama - Prof., INBI Matei Bals Bucharest, Romania
    Title: “National Institute of Infectious Diseases Prof Dr Matei Bals’ experience in clinical trials with new active molecules on hepatitis B and C.”

    9:45-10:15 AM
    Laurentiu Micu - MD, PhD – Fundeni Hospital, Bucharest, Romania
    Title: "Clinical trials in HCV chronic infections: a success story."


    10:15-10:45 AM
    Iulia Chiriac - MD – C.I.Parhon” National Institute of Endocrinology, Bucharest, Romania
    Title: "BIOMAT-ENDO: preliminary results on 2000 thyroid carcinoma cases"

    10:45-11:15 AM
    Jack Whelan – Research Advocate USA - 10:45-11:15 AM
    Title : “Convergence of biomarker-based Clinical Trials and new Information Technology dramatically changes the CRO, Central Labs and BioPharma industry. Ready?”
  • 11:15-11:45MORNING COFFEE AND NETWORKING BREAK

  • 11:45-13:00LABORATORY SECTION

    Chairman for Laboratory Section:
    Michael Oellerich - MD, PhD - “George-August” University, Medical Faculty, Gottingen, Germany

    11:45-12:05 AM
    Cristina Florescu Moraid - MD, MSc, EuSpLm-Regional Country Director, Synevo Central Lab, Romania
    Title: ”Pre-analytical phase of laboratory testing-true challenge for laboratory?”

    12:05-12:30 PM
    Dunja Rogic - MD, PhD – Clinical Institute of Laboratory Diagnostics, Clinical Hospital Center Zagreb, Croatia
    Title: „Interpretative comments - adding quality in postanalytical phase”

    12:30-13:00 PM
    Michael Oellerich - MD, PhD - Professor of Clinical Chemistry at the Medical Faculty, George-August-University Göttingen, Germany
    Title: “Laboratory medicine – challenges and opportunities”
  • 13:00-14:00 BUSINESS LUNCH BREAK

    Hotel Intercontinental
  • 14:00-16:00CRO & SPONSOR SECTION

    Moderator Sectiunea CRO & SPONSOR
    Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland

    14:00-14:30 AM
    Ivan Georgiev MD - Country Manager Quintiles Bulgaria
    Title: Romania and Bulgaria on the map of global clinical trials

    14:30-15:00 AM
    Eduard PADURARU -Clinical Operations Project Manager Servier Pharma Romania
    Title: Clinical operations : between CRO and Sponsor

    15:00-15:30 AM
    Regio Tanaseanu - MD - PSI CRO AG Romania
    Title: "Setting up a microbiology lab – case study"

    15:30-16:00 AM
    Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland
    Title: ”Start up Planning for Multinational Studies”

  • 16:00-16:15AFTERNOON COFFEE AND NETWORKING BREAK

  • 16:15-18:15REGULATORY & VARIA SECTION

    Chairman Regulatory & Varia Section

    Cristina Florescu Moraid - Synevo Central Lab Regional Director

    16:15-16:40 AM
    Lina Gudima - Manager of Clinical Trials Department, National Drug Agency, Republic of Moldova
    Title: “Clinical trials in Republic of Moldova”

    16:40-17:00 AM
    Constantin Mircioiu - MD, PhD-President of Pharmaceutical Department, Academy of Medical Sciences, National Commission of Bioethics of Drugs and Medical Devices, Romania
    Title: “Bio-statistical and Bio-pharmaceutical Components of Clinical Trials”

    17:00-17:30 AM
    Assoc. JANOSI ISTVAN - Managing Director, PLANIMETER, HUNGARY
    Title: "Electronic Case Report Form - State of the Art"

    17:30-18:00 AM
    Marius Geanta - MD - CEO Center for Innovation in Medicine, Bucharest, Romania
    Title: “Rethinking medicine: personalized medicine for Romanian patients”
  • 18:00-18:15TOMBOLA

  • 18:20-19:00Musical Soiree

    ETNOTHIC
  • 19:00-19:30Closing the session and grant diplomas


LECTORS

JANOSI ISTVAN Assoc. - PLANIMETER, HUNGARY

István Jánosi

PLANIMETER, HUNGARY


István graduated at KLTE, in Debrecen, Hungary as a mathematician in 1990.

He has been working as biostatistician since then. He spent four years at Semmelweis Medical University (Budapest) supporting the academic research conducted by the university teams and individuals.

After the Berlin wall fell a very sparkling life started in Hungary with marketing hundreds of new drugs to a market which required new study results including Hungarian patients. After a short freelancer period István started Planimeter Kft, a full service CRO which still has been managed by him. He designed, evaluated and reported numerous studies covering pre-clinical, Phase I-IV studies and post-marketing surveys during 25 years of his activity. Beyond acting as statistician István also collected rich experiences in Data Management. With his team he implemented an electronic CRF system which currently operates in 8 countries and designed several Patient Registries.

He also works as contract statistician time-by-time. He started with Accovion in 2009 and continued with CSL Behring in 2011, Bayer Healthcare (2013) and Novartis (2015). István has been a member of ISCB (International Society for Clinical Biostasticians) since 1990 and DIA (Drug Information Association) from 2013. Author or co-author of several publications, including a book on Statistics (in Hungarian).

Dunja Rogic - MD, PhD – Clinical Institute of Laboratory Diagnostics, Clinical Hospital Center Zagreb, Croatia

Professor Dunja Rogić, PhD

Clinical Institute of Laboratory Diagnostics, Clinical Hospital Center Zagreb, Croatia


Prof. Dunja Rogić, PhD, medical biochemistry specialist, graduated in 1986 from School of Pharmacy and Biochemistry, University of Zagreb, in the 1986-1987 period she did postgraduate study at School of Pharmacy and Biochemistry, University of Zagreb, she was in the 1987-1992 employed in Laboratory for Endocrinology, University Hospital Center Zagreb, in 1991 defended her master's thesis, in the 1992-1995 period was a resident in laboratory medicine (in 1995 she passed specialist exam in laboratory medicine), was Head of General Clinical Chemistry Laboratory, University Hospital Center Zagreb in the 1995-2002 period, won her PhD degree, and was awarded MBA degree - Leadership and Management in Health Services, Zagreb University School of Medicine and London School of Economics (2001-2003). In 2008 she was elected Assistant Professor at School of Pharmacy and Biochemistry, University of Zagreb, and since 2013 she has been Head of Department of Laboratory Diagnostics, University Hospital Center Zagreb, and Associate Professor at School of Pharmacy and Biochemistry, University of Zagreb.

She has been an invited speaker/participant in many scientific meetings in Croatia and abroad, author and co-author of more than 50 scientific papers. Her fields of interest: evidence-based medicine, POCT, organization & management of clinical laboratory, laboratory parameters of renal diseases. She has been a lecturer and organizer of continuous education courses for physicians and medical biochemists, and editor/co-editor of several textbooks and author of book chapters. She is a full member of EFLM Postanalytical WG. She is actively involved in undergraduate and graduate teaching at School of Pharmacy and Biochemistry, University of Zagreb, and School of Medicine, University of Zagreb; course leader: Evidence-based Laboratory Medicine.

Michael Oellerich - MD, PhD - Professor of Clinical Chemistry at the Medical Faculty, George-August-University Göttingen, Germany

Michael Oellerich

Professor of Clinical Chemistry at the Medical Faculty, George-August-University Göttingen, Germany


Michael Oellerich, MD, Hon MD, FACB, FAMM, FFPath (RCPI), FRCPath, is a chemical pathologist. Since 2012, he has an appointment as a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August-University Göttingen, Germany. He was chairman of the Department of Clincal Chemistry/Central Laboratory at UMG from 1991 to 2012. He received the Fellowship of the Royal College of Pathologists (FRCPath) in 2006, as well as the Fellowship of the National Academy of Clinical Biochemistry (FACB) of the American Association for Clinical Chemistry in 2012. Since 2013, he is a member of the Medical Advisory Board of Chronix Biomedical Inc., San Jose, CA, USA. From 1996 to 1998, he served as Dean of the Faculty of Medicine and as the deputy of the chief executive for research and teaching on the executive board for the Medical Center and Faculty of Medicine from 1999 to 2004. He was president of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) from 1997 to 1999, president of the German Association for Laboratory Medicine from 2001 to 2002, president of the German United Association for Clinical Chemistry and Laboratory Medicine (2003-2005), secretary-treasurer of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) from 2005 to 2007, president of WASPaLM from 2009 to 2011, and immediate past-president of WASPaLM from 2011 to 2013. Since 2016, he is secretary of the International Society of Enzymology. Currently he is the Director Europe of WASPaLM and chair of the board of the Labs Are Vital consortium. From 1999 to 2010, he was a member of the Steering Committee of EUROLIFE, a network of European centers of excellence in life sciences. Since 2003, he is Editor-in-Chief of the journal Therapeutic Drug Monitoring. He was Associate Editor of Clinical Biochemistry (1996–2007), Associate Editor of Clinical Chemistry (2007-2013), and Guest Editor of Clinica Chimica Acta (special issue) in 2012. He was on the Editorial Board of Clinical Chemistry (2002-2007; 2014-2016), and currently is on the Editorial Boards of Clinical Biochemistry (2015-) as well as of J Mol Clin Pathol, Folia Med, Turk J Pediatr Biochem, and Indian J Clin Biochem. He is member of the Advisory Boards of Ital J Lab Med and Braz J Pathol Lab Med. His current research interests are in the field of therapeutic drug monitoring, with particular focus on endogenous biomarkers to achieve personalised immunosuppression in transplantation (e.g.graft-derived circulating cell-free DNA as “liquid biopsy”), as well as genotype-directed cancer care using cfDNA. Further topics include proteomics, and analytical techniques (e.g. LC-MS/MS). He has authored more than 400 publications (articles contributed to scientific journals, book chapters, books edited).

He served as External Examiner for the Second Professional Examination 2009/2010 of the Faculty of Medicine at the Chinese University of Hong Kong. He received the following awards: Ludolf-Krehl prize of the S.W. German Society for Internal Medicine in 1971, the IATDMCT Award, Cairns (Australia) 1999, the IATDMCT Charles Pippenger Award for Outstanding Contributions to Therapeutic Drug Monitoring, Washington (USA) 2001, the 2002 Canadian Society of Clinical Chemists Travelling Lectureship Award, the Professor-Landbeck-Award of the Society for Thrombosis and Hemostasis Research, Hamburg (Germany) 2004, the Perth PathCentre Visiting Lectureship, Western Australia 2004, the Honorary Fellowship of the Faculty of Pathology of the Royal College of Physicians of Ireland (FFPath RCPI), Dublin 2006, the Honorary Membership of the Romanian Society of Laboratory Medicine, Sibiu 2007, the WASPaLM Medal of Honor, Las Vegas (USA) 2011, the membership of the Bulgarian Academy of Sciences and Arts (BASA), Sofia 2012, the WASPaLM Gold Headed Cane, Quebec City (Canada) 2013, and the IATDMCT Honorary Membership, Salt Lake City (USA) 2013.

Jack Whelan – Research Advocate USA

Jack Whelan

Research Advocate USA


Jack Whelan is an eight year survivor of a rare, incurable blood cancer moving from a career IT Research Analyst to Research Advocate; he was recently diagnosed with an aggressive form of metastatic prostate cancer for which he is in treatment. Travel with Jack on an intensely personal and often humorous bumpy ride on the road to Personalized Medicine which is still under construction as he participates in seven Clinical trials. Using business communications and research skills coming from his career as a Wall Street Research Analyst and career Sales VP in IT, he now helps bridge the communications gap between life sciences, medical professionals and patients. Jack hopes all appreciate the real value and noble work of life sciences employees and companies involved in cancer research and care. A decided friend to BioPharma and CROs as an engaged, informed e-Patient Opinion Leader (POL) and Advocate he regularly speaks to and for these companies, to open much-needed communications lines with patients, providers and policymakers. He encourages all patients to explore novel targeting agents and immunotherapies many of which are now in Clinical Trials. Using genetic and genomic information to develop new disease-specific targeted therapeutics might be safer and more effective treatment than conventional chemotherapy.

Jack’s a frequent speaker and participant at the best industry and advocacy conferences in the Americas and Europe sharing his engaging, gripping, hopeful and fun story about survival. Jack understands the realities of his blood cancer as he has repeatedly relapsed and has been refractory to most of the therapies received thus far; however his goal is repeated periods of progression free survival during which the promise of science and delivery of successful therapeutics will be achieved. His website is located at Jack-Whelan.com

Other information of potential interest:

In advocacy he’s an active member with AACR, ASCO, DIA, LLS, RDLA, NORD, NIH’s NCTN, ACRES and Transcelerate as Patient Advocate focused on Clinical Trials. He lives in Andover Massachusetts with his wife Jan, has three ‘fabulous’ daughters and sons-in-law and proud grandparents of six grandkids four of whom are twins He’s an associate member of the American Association for Cancer Research (AACR), completed the 2013 and 2014 Scientist-Survivor Programs and Science of Cancer Disparities in Research program, featured cover story of AACR’s Cancer Today Magazine, the AACR Annual (2014) Cancer Progress Report and appears in one of AACR’s national network TV fundraising commercials. He was a speaker at AACR’s 2015 and 2016 Annual Meeting. As a strong proponent of rational funding for biomedical research and to convince Congress to make this a national priority he will participate in his third AACR-led Rally for Medical Research this Sept ’16. Jack has been an event speaker for and is a strong supporter of AACR Foundation. He serves on the editorial board of AACR’s Cancer Today Magazine.

He is also active with the American Society of Clinical Oncology (ASCO), completed the Research Advocacy Network Focus on Research Scholars in conjunction ASCO’s Patient Advocacy Education Programs in 2013, 2015 and 2106. He serves on ASCO’s Patient Advisory Committee advising and promoting ASCO’s CancerLinQ EHR development programs. He is also active with and completed the Drug Information Association (DIA) Patient Advocate Fellowship Program in, has produced educational videos & webcasts for DIA. Jack is a keynote speaker and Co-Chair of the Research Advocacy Council of the Alliance for Clinical Research Excellence and Safety (ACRES) and member of the Patient Advisory Board at Transcelerate, both organizations are strong proponents of improving the Clinical Trials industry.

He’s an active volunteer with the International Waldenstrom’s Macroglobulinemia Foundation (IWMF) a charitable advocacy that provides patient education, support and funds research. He is IWMF’s New England Support Group Leader and a keynote speaker at IWMF’s Annual Educational Patient-Physician Forum.

He's active with Leukemia & Lymphoma Society (LLS) as speaker recruiting for LLS’ Team in Training and Light the Night, a First Connection patient advocate; he’s a speaker at local LLS’ support groups. He received the LLS’ 2014 Quality of Life Award and a 2016 Fight Against Blood Cancer Award. As a Legislative Advocate with LLS, he helped convince state lawmakers to pass the much-needed Oral Chemotherapy Parity bill, by participating in lobbying efforts at the state house, writing stories for print and broadcast press, and conducted email and phone call campaigns to help educate lawmakers. He is also a champion for new legislation centered on Biosimilars clarification, Step Therapy and Specialty Tiers bills.

With the Rare Disease Legislative Advocacy (RDLA) and National Organization for Rare Disorders (NORD) he has appeared before several Congressional delegations; he helps educate Federal lawmakers about much-needed legislation to encourage more funding for biomedical research and effective, efficient & up-to-date healthcare policies.

For the past several years, Jack has been a fundraiser and volunteer spokesman on radio and TV with the Jimmy Fund and Boston Red Sox for the benefit of Dana Farber Cancer Institute (DFCI). He is featured in a national TV commercial about his treatment at DFCI. Jack is a former Co-chairman of DFCI's Patient Family Advisory Council (PFAC). He served on the Institute’s Patient Advisory Committee on the Epic EMR system upgrade program.

Described as "a one man band with a loud drum to engage and motivate others", with a busy 2016 calendar, you may find Jack speaking at advocacy, healthcare, medical education and Life Sciences professional events around the United States and Europe. Jack is a graduate of the University of Rhode Island and United States Navy veteran.

Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland

Dr. Med. Julian V. Platon

R&D and Medical Affairs Consultant, Switzerland


Dr. Platon has been born in Bucharest, Romania in 1963. After his A Level in Bucharest he relocated to Germany in 1983 where he obtained the German Matura and studied Medicine in Cologne, London and Beer-Sheva. In parallel to his Conferral of Doctorate in Surgery he worked as a physician in the Department of Internal Medicine in Cologne, Germany.

Since 1994 Dr. Platon had different national and international, operational and executive medical positions in the Pharmaceutical, Medical Devices and Clinical Research Organization industry in Germany, USA and Switzerland. A special focus was addressed to Medical Affairs, Clinical Development & Operations and Pharmacovigilance (incl. QPPV). Stations of his professional life were Schwarz Pharma, Hoffmann-La Roche, Abbott, PharmaPart, Solvay and Alexion.

Dr. Platon is married, has three children and lives in Basel, Switzerland where he works as strategic and operational consultant in R & D and in Medical Affairs.

julian.platon@gmail.com

Victoria Arama - INBI Matei Bals Bucharest, Romania

Dr. Victoria Arama

Sef de Sectie la Institutul National de Boli Infectioase Prof Dr Matei Bals Bucuresti


Dr Victoria Arama este medic primar - Sef de Sectie la Institutul National de Boli Infectioase Prof Dr Matei Bals Bucuresti, avand titlul de Profesor universitar la UMF Carol Davila Bucuresti, Facultatea de Medicina, Disciplina de Boli Infectioase - Matei Bals.

Domeniile sale stiintifice de interes sunt reprezentate de: Infectiile virale (virusuri herpetice, virusuri hepatitice, infectia HIV/SIDA, virusuri gripale, papilomavirusuri); Terapia antivirala; Vaccinologia ; Rezistenta bacteriana la antibiotice; Infectiile in sarcina; Infectiile la imunodeprimati; Infectiile fungice si terapia antifungica.

In ceea ce priveste activitatea de cercetare stiintifica, Prof Dr Victoria Arama a fost coordonator stiintific sau membru in echipa de cercetare a numeroase granturi stiintifice castigate prin competitii nationale si internationale, precum si investigator principal in peste 40 de trialuri clinice internationale.

Din punct de vedere al activitatii stiintifice, Prof Dr Victoria Arama este autor a 4 monografii stiintifice si a peste 40 de capitole in alte monografii. Este membra a numeroase societati stiintifice nationale si internationale (ISID, ECCMID, EASL, GEEP, IHMF) si a publicat ca autor / coautor peste 500 lucrari stiintifice in reviste medicale din tara si strainatate.

Prof Dr Victoria Arama este membra in Comitetul Stiintific al revistei medicale franceze Medecine et Maladies Infectieuses si membra in Comitetul Editorial la alte 7 reviste medicale romanesti recunoscute.

Lina Gudima - MD - ANM Moldova

Dr. Gudima Lina

ANM Moldova


10/2005–17/09/2007

Medical doctor
Municipal Clinical Hospital "Railway" of Moldova, Chishinau (Moldova)
09/2007–06/2012
Medical doctor
Medicines and Medical Devices Agency, Medicines authorisation department, Chishinau (Moldova)
authorisation of medicines
06/2012–Present
Medical doctor
Medicines and Medical Devices Agency, Clinical Trials Research Department, Chishinau (Moldova)
Head of Clinical Trials Research Department
2007–2012
Medical doctor
Medicines and Medical Devices Agency, Chishinau (Moldova)
member of working group within the MMDA for centralized procurement
12/2014–2016
Medical doctor, Pharmacovigilance trainer
Center of Health Policies and Studies of Republic of Moldova, Chisinau (Moldova)
Pharmacovigilance in introduction of new anti TB products
31/03/2012–31/03/2012
Clinical Trials according to GCP
Arensia Exploratory Medicine GmbH, Chishinau (Moldova)
04/10/2012–05/10/2012
master-calss – Quality assurance and control in clinical trials
The State Expert Center of the MoH of Ukraine, Kyiv (Ukraine)
13/10/2012
GCP Training for Investigators
Hoffman la Roche, Chishinau (Moldova)
04/10/2012–05/10/2012
participant of the 4-th scientific and practical conference with international participation „Clinical trials of medicinal products in Ukraine
The National Academy of Medical Sciences of Ukraine, Kyiv (Ukraine)
12/10/2012 “Основы международной регистрации лекарственных средств”
Vialek Ukraine, Chishinau (Moldova)
23/11/2012–24/11/2012 speaker
„Synevo 2012 – Conference for Clinical Trials”presentation „Challenges in conducting clinical trials in
the Republic of Moldova, Bucharest (Romania)
25/06/2013–26/06/2013 Cerificate of completion: Introduction to the Clinical Drug
Development Process: ICH Good Clinical Practice for Clinical Trials
Sites
Quintiles Global Talent, Development and Engagement, Chishinau (Moldova)
23/10/2013–25/10/2013 Training course
Practical GCP Compliance Auditing of Trials and Systems, London (United Kingdom)
16/03/2013 GCP Refresher Training
Arensia Exploratory Medicine, Chishinau (Moldova)
18/04/2013–19/04/2013 6-th Annual CIS and SEE Clinical Trials
Fleming Europe, Zagreb (Croatia)
05/2013 The training of internal auditors and managers in the standards
system in SM SR EN ISO 9001:2011; SM SR EN ISO/CEI
17025:2006 and SM SR EN ISO 19011:2012
National Institute of Standardization and Metrology Moldova, Chishinau (Moldova)
09/09/2013–12/09/2013 speaker
scientific-practical conference MoldMedizin 2013 in the exhibition "Rational use of medicines ",
Chishinau (Moldova)
07/09/2014–09/09/2014 speaker
development project "Strengthening the Moldovan pharmaceutical sector and Medical Devices
Agency for Medicines and" Speaker "Clinical Trials in Moldova" and "Marketing Authorisation
procedure in Moldova", Tartu (Estonia)
18/03/2015 Экспертиза регистрационного досье в формате СТD Модуль 1-3
Vialek, Chishinau (Moldova)
29/02/2016–01/03/2016 Participant work-shop HINARI- health research
MoH, Moldova and WHO, regional office for Europe, Chishinau (Moldova)

Cristina Florescu Moraid - MD, MSc, EuSpLm - Synevo Central Lab Romania

Cristina Florescu-Moraid, MD, MSc, EUSpLM

Synevo Central Lab Country Director Romania, Republic of Moldova, Bulgaria & Serbia


Cristina Florescu-Moraid is responsible for Synevo Central Lab’s operations in Romania since 2005. Cristina Florescu-Moraid was responsible for management of more than 80 studies and was involved in another 100 projects prior to her manager career. Cristina Florescu-Moraid got her Medical Doctor Diploma in 1997 from Carol Davila University of Medicine and Pharmacy in Bucharest, Romania and was accredited as Laboratory Medicine Specialist in 2005 and as Senior Laboratory Medicine Specialist in 2011, by the Romanian College of Physicians.

Dr. Florescu Moraid got her Master of Science Diploma in 2006 from Health Insurance National House and accomplished Postgraduated School of Clinical Trials Management at Gdansk Foundation for Management Development Gdansk in 2012. She graduated the Postgraduated Leadership Development Programme at University of Sussex, UK in 2014.

She is invited speaker for laboratory medicine and clinical research scientifc events and organize several courses and trainings for specialists working in clinical trials field.

Dr. Florescu-Moraid has more than 10 years of experience in laboratory and clinical trials industry now.

Tomasz Anyszek, MD, PhD - Synevo Poland and Synevo Central Lab Director

Dr. Tomasz Anyszek

Director of Synevo Central Lab since 2009 and Synevo Polska laboratory since 2014


Dr. Tomasz Anyszek is Director of Synevo Central Lab since 2009 and Synevo Polska laboratory since 2014.He is responsible for clinical trials operations in more than 40 laboratories in Central and Eastern Europe. Dr. Anyszek started his career with Virtual Central Laboratory, Netherlands in 2000 (Covance VCL since 2003) and his experience also includes the coordination of 16 regional Covance partner laboratories in Europe. During this period he performed 200 audits in clinical laboratories. Dr. Anyszek holds his PhD from Jagiellonian University, Poland. Prior to his business career, he taught clinical biochemistry and laboratory medicine at the Jagiellonian University medical faculty. Dr. Anyszek has authored more than 20 scientific publications and co-authored several books and monographies in the clinical chemistry and laboratory medicine area.

He is invited speakers for many conferences held in laboratory medicine and clinical research area.

He is married and has two daughters.

Laurentiu Micu - MD, PhD – Fundeni Hospital, Bucharest, Romania

Dr. Laurentiu Micu

Clinica de Medicina Interna, Institutul Clinic Fundeni, Bucuresti


Am absolvit Facultatea de Medicina Generala din cadrul Universitatii de Medicina si Farmacie Carol Davila Bucuresti in anul 1996.
In anul 2000 am obtinut titlul de medic specialist medicina generala, din 2005 - medic specialist medicina interna, iar din 2012 – medic primar medicina interna.
Angajat al Clinicii de Medicina Interna, Institutul Clinic Fundeni, din 2001 ca asistent cercetare stiintifica medicina interna, iar din 2007 ca cercetator stiintific.
In anul 2008 am obtinut titlul de Doctor in Medicina cu lucrarea: Factori predictivi ai raspunsului la tratamentul antiviral in infectiile cronice VHB si VHC (sub coordonarea Dlui Prof. Dr. Lucian Buligescu).
In prezent sunt membru al Subcomisiei de Hepatologie din Ministeul Sanatatii si Coordonator Secundar de Cercetare in Institutul Clinic Fundeni.
Din punct de vedere al activitatii stiintifice:
- peste 150 prezentari orale si sub forma de poster la simpozioane si congrese nationale si internationale - peste 40 articole publicate in reviste de specialitate;
- investigator principal sau subinvestigator in peste 25 studii clinice de faza II, III si IV';
- membru in Comitetul Executiv al Asociatiei Romane pentru Studiul Ficatului;
- membru al Asociatiei Romtransplant, al Societatii Romane de Gastroenterologie, Hepatolgie si Endoscopie Digestiva si al Societatii Romane de Medicina Interna;
- membru in comitetul de redactie al revistelor Journal of Translational Medicine and Research si The Lancet Oncology, editia romana.

Marius Geanta, MD - CEO Center for Innovation in Medicine, Romania

Marius Geanta, MD

CEO Center for Innovation in Medicine, Romania


Co-founder of the Center for Innovation in Medicine. National Task Force Manager for România of Public Health Genomics Network. Expert on the European personalized medicine Development Platform Member of the European Alliance of Personalized Medicine Participant IT Future of Medicine project Founder and general manager of specialized medical communication Kol Medical Media Editor- Chief of the journal Hippocrates, the medical community reference brand in Romania.

Iulia Chiriac - Secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară

Iulia Chiriac

Secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară


Am urmat cursurile de pregătire a Facultății de Medicină Generală din cadrul Universității de Medicină și Farmacie “Carol Davila” București între 2006-2012, iar din 2013 am început specializarea în Medicină Nucleară sub îndrumarea coordonatorilor de la Spitalul Universitar de Urgență Militar Central “Dr Carol Davila”. Din aprilie 2016 sunt angajată la Institutului Național de Endocrinologie “CI Parhon” București în Departamentul de Medicină Nucleară, Compartiment Cronici-Terapie Izotopică. În iunie 2015 am devenit secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară. Din iulie 2015 am început să lucrez la proiectul “BIOMAT-ENDO: construcția bazei de date digitale pentru monitorizarea pacienților cu cancer tiroidian”. Acest proiect urmărește să digitalizeze informațiile cu ajutorul unui software tip "baza de date" , urmat de etapa pregătirii acestor date pentru analiza lor prin metode de statistica matematica. O parte din parametrii de interes sunt: zona geografică de proveniență a pacienților cu cancer tiroidian, vârsta actuală a pacienților, sexul, debutul bolii, factori genetici, tipul intervenției chirurgicale inițiale, dar și a reintervențiilor, rezultatul anatomo-patologic, doza totală terapeutică de 131I, valorile marker-ilor tumorali sau hematologici, precum și altele. Din punct de vedere al activității științifice sunt încă la început de drum, dar am participat cu lucrări la mai multe conferințe și congrese naționale și internaționale de profil.

REGISTRATION FORM - SYMPOSIUM REGISTRATION FEE

00

days


00

hours


00

minutes


00

seconds


REGISTRATION CLOSED

We are sorry to announce that due to high demand, we have reached the capacity for this event.

If you are still interested to participate, please send us your request and let us know why you would like to attend.

After analyzing your request, we will inform you our decision.

SYMPOSIUM REGISTRATION FEE

1st Octomber - 24th November 2016, Euro 50 for one participant

25th November / on desk registration fee, Euro 100 for one participant

Terms and Conditions:
By sending this form, I hereby confirm that I have read and accepted the terms and conditions detailed below.
Confirmation:
For free registration: we will confirm your registration withing 48 hours after sending us your application. If you will not here from us, after 48 hours from the time of sending your application, please call us or contact by email: symposium@synevo.eu
For registration during fee applicable period: The delegate will receive the proforma invoice together with event venue location within 48 hrs of sending the registration form.
If, within 48 hours after sending your registration, you will not receive details from us, please call us or contact by email: symposium@synevo.eu
Cancellations:
Made one month prior to the start of the conference will be refunded less 50% administration charge. Refunds will be made after the conference. Cancellations made within one month of the conference start date will receive no refund. Substitutes are accepted up to 3 days before the conference. Any cancellation will be accepted latest one month before the event and should be informed in written form.
By sending this form, I confirm that I have read and accepted the terms and conditions detailed above.

Registration Form

LOCATION

Bucharest Intercontinental Hotel